> Skip to content
FEATURED:
  • Student-Success Resource Center
Sign In
  • News
  • Advice
  • The Review
  • Data
  • Current Issue
  • Virtual Events
  • Store
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
  • Jobs
    • Find a Job
    • Post a Job
    • Career Resources
    • Find a Job
    • Post a Job
    • Career Resources
Sign In
  • News
  • Advice
  • The Review
  • Data
  • Current Issue
  • Virtual Events
  • Store
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
  • Jobs
    • Find a Job
    • Post a Job
    • Career Resources
    • Find a Job
    • Post a Job
    • Career Resources
  • News
  • Advice
  • The Review
  • Data
  • Current Issue
  • Virtual Events
  • Store
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
  • Jobs
    • Find a Job
    • Post a Job
    • Career Resources
    • Find a Job
    • Post a Job
    • Career Resources
Sign In
ADVERTISEMENT
News
  • Twitter
  • LinkedIn
  • Show more sharing options
Share
  • Twitter
  • LinkedIn
  • Facebook
  • Email
  • Copy Link URLCopied!
  • Print

Many Academics Use Drugs to Enhance Their Brain Power, Survey Suggests

April 10, 2008

College students have long resorted to popping Ritalin and other stimulants to give themselves a mental leg up, but an informal survey by Nature magazine reveals that many science professionals are also taking drugs for the express purpose of improving their cognitive capacities.

In an online survey of 1,400 readers, Nature found that 20 percent had taken pharmaceuticals for the nonmedical purpose of improving their concentration, focus, and memory. Most of the people who responded to the survey were involved in science, engineering, or education. “The numbers suggest a significant amount of drug-taking among academics,” the magazine said.

We're sorry. Something went wrong.

We are unable to fully display the content of this page.

The most likely cause of this is a content blocker on your computer or network.

Please allow access to our site, and then refresh this page. You may then be asked to log in, create an account if you don't already have one, or subscribe.

If you continue to experience issues, please contact us at 202-466-1032 or help@chronicle.com

College students have long resorted to popping Ritalin and other stimulants to give themselves a mental leg up, but an informal survey by Nature magazine reveals that many science professionals are also taking drugs for the express purpose of improving their cognitive capacities.

In an online survey of 1,400 readers, Nature found that 20 percent had taken pharmaceuticals for the nonmedical purpose of improving their concentration, focus, and memory. Most of the people who responded to the survey were involved in science, engineering, or education. “The numbers suggest a significant amount of drug-taking among academics,” the magazine said.

The survey focused on three drugs: Ritalin, the anti-sleep drug Provigil, and beta blockers (which are used to treat cardiac conditions but can also reduce anxiety). Over 60 percent of the people who admitted using the drugs for cognitive reasons said they used Ritalin, while 44 percent said they used Provigil, which is known generically as modafinil. Some 15 percent said they used beta blockers.

Respondents who said they used such drugs were evenly split between people who said they took them daily, weekly, monthly, and once a year. Nine out of 10 of those respondents said they used the medications to improve concentration and attention. Many said they took them to enhance memory, problem-solving, and planning.

The numbers revealed by the survey show that “scientists are not immune to substance abuse,” said Wilson M. Compton, director of the division of epidemiology, services, and prevention at the National Institute on Drug Abuse. In an interview with The Chronicle, Dr. Compton said, “This is an example where you think people who are highly educated and knowledgeable might know better, and that’s not necessarily the case.”

ADVERTISEMENT

Because the survey was not a scientific study, he said, it would be impossible to draw wider conclusions about how many people inside or outside academe actually use such drugs.

Dr. Compton was most concerned by the high percentage of people who said they were taking Ritalin, which can be addictive. “The attitude toward these drugs indicated by this survey is that people see them as being safe and not a concern,” he said. “That’s a problem when these are potentially addictive and can be associated with complications.”

Provigil is less well-known than Ritalin, and Dr. Compton said it was not known whether it was addictive. The drug helps people stay awake and is most often prescribed for treating narcolepsy and other sleep disorders.

Nature decided to conduct its survey as a follow-up to a commentary late last year by two scientists who reported that several colleagues were using Provigil to work longer hours and improve their concentration. In an article in The Chronicle in December, Martha J. Farah, a professor of psychology at the University of Pennsylvania, said that many academics used Provigil to alleviate the symptoms of jet lag when attending conferences overseas. She said she had obtained a prescription for that purpose and had used it twice on trips. “I found myself marveling at just how clearheaded and comfortable I felt,” she said.

According to Dr. Compton, academics generally use beta blockers for different purposes, such as to counteract the rapid heart beat and hand tremors that some people experience when giving public talks. —Richard Monastersky

ADVERTISEMENT

We welcome your thoughts and questions about this article. Please email the editors or submit a letter for publication.
ADVERTISEMENT
ADVERTISEMENT
  • Explore Content
    • Latest News
    • Newsletters
    • Letters
    • Free Reports and Guides
    • Professional Development
    • Virtual Events
    • Chronicle Store
    • Chronicle Intelligence
    • Find a Job
    • Post a Job
    Explore Content
    • Latest News
    • Newsletters
    • Letters
    • Free Reports and Guides
    • Professional Development
    • Virtual Events
    • Chronicle Store
    • Chronicle Intelligence
    • Find a Job
    • Post a Job
  • Know The Chronicle
    • About Us
    • Write for Us
    • Work at The Chronicle
    • Our Reporting Process
    • Advertise With Us
    • Brand Studio
    • DEI Commitment Statement
    • Accessibility Statement
    Know The Chronicle
    • About Us
    • Write for Us
    • Work at The Chronicle
    • Our Reporting Process
    • Advertise With Us
    • Brand Studio
    • DEI Commitment Statement
    • Accessibility Statement
  • Account and Access
    • Manage Your Account
    • Manage Newsletters
    • Individual Subscriptions
    • Institutional Subscriptions
    • Subscription & Account FAQ
    Account and Access
    • Manage Your Account
    • Manage Newsletters
    • Individual Subscriptions
    • Institutional Subscriptions
    • Subscription & Account FAQ
  • Get Support
    • Contact Us
    • Reprints & Permissions
    • User Agreement
    • Terms and Conditions
    • Privacy Policy
    • California Privacy Policy
    • Do Not Sell My Personal Information
    Get Support
    • Contact Us
    • Reprints & Permissions
    • User Agreement
    • Terms and Conditions
    • Privacy Policy
    • California Privacy Policy
    • Do Not Sell My Personal Information
1255 23rd Street, N.W. Washington, D.C. 20037
© 2023 The Chronicle of Higher Education
  • twitter
  • instagram
  • youtube
  • facebook
  • linkedin